Skip to content

ARWR

Arrowhead Pharmaceuticals, Inc.

Key figures

MetricLast 12 months5-year CAGR
Revenue$451M+26.7%
Operating income−$707M—
Net income−$724M—
EPS−$5.11—
Free cash flow−$284M—